Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |